measurement of serum sodium, potassium and renal function. We recommend that patients with hypernatraemia should be managed as a medical emergency with a level 2–3 care or equivalent high dependency setting. Patients with CDI may not be polyuric at
Search Results
S E Baldeweg, S Ball, A Brooke, H K Gleeson, M J Levy, M Prentice, J Wass, and the Society for Endocrinology Clinical Committee
M S Elston, V B Crawford, M Swarbrick, M S Dray, M Head, and J V Conaglen
laboratory investigations at initial assessment. Analyte Result Reference interval Serum potassium 2.3 3.5–5 mmol/L Glucose 11.6 <7.8 mmol/L HbA1c 33 <41 mmol/mol Serum cortisol (1104 h) >1655 200
Punith Kempegowda, Eka Melson, Agnes Johnson, Lucy Wallett, Lucretia Thomas, Dengyi Zhou, Catherine Holmes, Agata Juszczak, Mohammed Ali Karamat, Sandip Ghosh, Wasim Hanif, Parth Narendran, and Srikanth Bellary
-hydration, insulin, and potassium monitoring ( 3 , 5 ). The mortality of DKA is 0.67% outside the context of COVID-19 ( 6 ). Mortality rates associated with DKA in the presence of COVID-19 are unknown. Chamorro–Pareja et al. report a mortality rate of 50% in
Thera P Links, Trynke van der Boom, Wouter T Zandee, and Joop D Lefrandt
performance characteristics of various sodium potassium and calcium channels. This changes the intracellular levels of calcium and potassium, thereby influencing inotropy and chronotropy ( 1 ). Haemostatic system For the thyrotoxic state, an extensive
Hanna Karhapää, Siru Mäkelä, Hanna Laurén, Marjut Jaakkola, Camilla Schalin-Jäntti, and Micaela Hernberg
Events version 5.0 ( 16 ). Before treatment initiation, a standard spectrum of laboratory tests was taken including whole blood cell count (WBC), sodium, potassium, calcium, creatinine, glomerular filtration rate, aspartate and alanine aminotransferases
Soraya Puglisi, Paola Perotti, Mattia Barbot, Paolo Cosio, Carla Scaroni, Antonio Stigliano, Pina Lardo, Valentina Morelli, Elisa Polledri, Iacopo Chiodini, Giuseppe Reimondo, Anna Pia, and Massimo Terzolo
circumference, glycemic profile and lipid profile was reported ( Table 3 ). During treatment, sodium and potassium levels were in the normal range. Figure 2 UFC levels at Day 0 and Day 82 in seven patients treated with metyrapone. 165 nmol/24 h is the
Ghazala Zaidi, Vijayalakshmi Bhatia, Saroj K Sahoo, Aditya Narayan Sarangi, Niharika Bharti, Li Zhang, Liping Yu, Daniel Eriksson, Sophie Bensing, Olle Kämpe, Nisha Bharani, Surendra Kumar Yachha, Anil Bhansali, Alok Sachan, Vandana Jain, Nalini Shah, Rakesh Aggarwal, Amita Aggarwal, Muthuswamy Srinivasan, Sarita Agarwal, and Eesh Bhatia
), potassium channel regulator (KCNRG), bacterial/permeability-increasing fold-containing B1 (BP1FB1) and transglutaminase 4 (TGM4) antigens were measured by radioligand binding assays ( 24 ). Gastric parietal cell and liver/ kidney/ microsomal type 1
M de Fost, S M Oussaada, E Endert, G E Linthorst, M J Serlie, M R Soeters, J H DeVries, P H Bisschop, and E Fliers
samples were collected for the determination of plasma and urine sodium, potassium, and osmolality and of plasma AVP. There was no pre-set maximum length of water deprivation. Water deprivation was discontinued when one of the following criteria was met: i
Sandra Pereira, Jessy Moore, Jia-Xu Li, Wen Qin Yu, Husam Ghanim, Filip Vlavcheski, Yemisi Deborah Joseph, Paresh Dandona, Allen Volchuk, Carolyn L Cummins, Evangelia Tsiani, and Adria Giacca
samples collected after 48 h basal infusion studies were separated into cytosolic and membranes fractions for protein kinase C (PKC)-δ Western blots ( 13 ); purity of membrane fractions was confirmed by probing for sodium-potassium ATPase protein. Soleus
Thabiso R P Mofokeng, Salem A Beshyah, Fazleh Mahomed, Kwazi C Z Ndlovu, and Ian L Ross
in addition to serum sodium and serum potassium only, clinical features and serum sodium and/or serum potassium in addition to relevant antibodies, or clinical features in addition to low serum cortisol with synthetic ACTH (tetracosactide) stimulation